• SENSEX 78,890.97
    1,589.57 (+2.06%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,850.00 1,878.00(%)
  • ITC
    277.30 252.80(%)
  • Tube Investments
    2,227.65 2,006.00(%)
  • Axis Bank
    1,274.70 1,418.30(%)
  • Reliance Industries
    1,303.90 1,152.30(%)
  • HDFC Life Insur.
    546.00 788.50(%)
  • Aurobindo Pharma
    1,748.85 1,739.95(%)
  • Lenskart Solut.
    767.40 725.00(%)
  • HDFC Bank
    762.80 1,017.90(%)
  • Titan Company
    4,858.90 5,187.45(%)
  • Petronet LNG
    320.00 326.40(%)
  • CG Power & Ind
    812.40 525.50(%)
  • Jio Platforms
    1,442.00 1,490.00(%)
  • Tonbo Imaging
    1,460.00 1,343.80(%)
  • Multi Comm. Exc.
    3,395.00 3,537.00(%)
  • Larsen & Toubro
    4,071.00 4,440.00(%)
  • Saregama India
    613.80 305.65(%)
  • Bajaj Finance
    1,054.00 1,177.60(%)
  • Cummins India
    4,036.95 3,883.30(%)
  • Bajaj Auto
    10,750.10 12,470.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Natco Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Natco
  • BSE Code : 4684.0
  • ISIN : INE987B01026
788.75 7 (0.91%)
  • As on 05 Nov 2026 (EOD)

  • Today’s Low

    781.70

  • Today’s High

    797.80

  • Open

    781.70

  • Perv Close

    781.60

  • 52W Low

    773.60

  • 52W High

    1,216.81

Key Indicators

  • P/E(TTM)

    17.37

  • Mar.Cap (₹Cr.)

    15,472.75

  • Div & Yield %

    0.58

  • Book Value(₹)

    501.20

  • Debt-Equity Ratio

    0.91

  • AGM Date

    04-Nov-2026

  • EPS

    45.47

  • P/E Ratio

    17.37

Financials Ratios

  • Debt-Equity Ratio

    0.05

  • Mar.Cap (₹Cr.)

    15,472.75

  • RONW (%)

    25.88

  • ROCE (%)

    29.63

Score Board

  • Equity (₹ in Cr.)

    39.23

  • BV (₹)

    501.20

  • Sales( ₹ in Cr.)

    3,594.60

  • NP (in Cr.)

    1,299.73

  • NP Var(%)

    -27.0

  • Div%

    250.0

  • CPS (₹)

    75.90

  • EPS (₹)

    66.30

  • Traded Value (₹ in Lakhs)

    15,489.42

  • 52 Week High

    1,216.81

  • 52 Week Low

    773.60

  • Price BSE

    790.0

  • Price NSE

    789.00

  • Market Capital( in Cr.)

    15,489.42

  • P/C Ratio

    10.40

  • P/E Ratio

    11.90

  • Price Vs.BV

    66.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 3,594.60 4,094.50 3,568.90 2,351.00 1,767.80 1,653.50
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,594.60 4,094.50 3,568.90 2,351.00 1,767.80 1,653.50
Other Income 281.10 321.30 104.70 85.50 94.60 101.10
Stock Adjustments 69.20 -11.60 -17.20 -34.60 5.50 46.90
Total Income 3,944.90 4,404.20 3,656.40 2,401.90 1,867.90 1,801.50
EXPENDITURE :            
Raw Materials 642.90 581.70 557.30 495.10 540.10 546.90
Power and Fuel Cost 96.90 93.10 88.90 81.90 76.40 59.40
Employee Cost 591.70 515.30 454.90 425.70 410.10 380.00
Other Manufacturing Expenses 279.90 217.70 179.80 150.30 148.70 114.30
Selling and Administration Expenses 618.50 444.10 483.70 290.70 309.10 140.30
Miscellaneous Expenses 129.00 86.70 150.10 28.00 75.90 41.90
Employee Benefit Expenses 591.70 515.30 454.90 425.70 410.10 380.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,358.90 1,938.60 1,914.70 1,471.70 1,560.30 1,282.80
Operating Profit 1,586.00 2,465.60 1,741.70 930.20 307.60 518.70
Interest 32.30 19.60 14.50 8.60 13.30 11.30
Gross Profit 1,553.70 2,446.00 1,727.20 921.60 294.30 507.40
Depreciation 189.60 220.00 171.90 150.90 138.40 115.20
Profit Before Tax 1,364.10 2,226.00 1,555.30 770.70 155.90 392.20
Current Tax 268.40 407.50 284.80 133.10 32.50 93.30
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -185.80 -31.90 -36.10 0.50 -15.70 -10.60
Reported Net Profit 1,281.50 1,850.40 1,306.60 637.10 139.10 309.50
Extraordinary Items -18.23 72.22 -2.12 14.71 33.80 24.39
Adjusted Net Profit 1,299.73 1,778.18 1,308.72 622.39 105.30 285.11
Adjustment below Net Profit 15.30 3.00 -49.70 -1.00 0.40 2.20
P & L Balance brought forward 5,972.20 4,226.30 3,134.60 2,587.10 2,520.50 2,322.50
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 89.60 107.50 165.20 88.60 72.90 113.90
P & L Balance carried down 7,179.40 5,972.20 4,226.30 3,134.60 2,587.10 2,520.30
Dividend 0.00 0.00 170.20 100.40 82.10 113.90
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 250.00 300.00 475.00 275.00 225.00 262.50
Dividend Per Share(Rs) 5.00 6.00 9.50 5.50 4.50 5.25
Earnings Per Share-Unit Curr 71.59 103.37 72.99 34.91 7.62 16.96
Earnings Per Share(Adj)-Unit Curr 71.01 102.53 72.40 34.63 7.56 16.82
Book Value 477.80 409.72 312.42 257.64 229.69 224.17
Book Value(Adj)-Unit Curr 473.94 406.39 309.89 255.56 227.83 222.36

Shareholding Pattern

  • Promoter Group

    46.22%

  • Public Share Holding

    53.78%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 491,761 491,761.00 491,761 491,761
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 491,761 0.25 491,761 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 34,244,926 17.46 34,244,926 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 51,183,958 26.09 51,183,958 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 4,756,257 2.42 4,756,257 4
Others 0 0.00 0 0
Sub Total 90,185,141 45.97 90,185,141 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 25 0.00 25 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 30,132,034 15.36 30,132,034 213
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 7,009,887 3.57 7,009,887 17
Mutual Funds / UTI 13,758,341 7.01 13,758,341 24
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 454,159 0.23 454,159 16
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 51,354,446 26.18 51,354,446 271
2] Non Institution
Bodies Corporate 2,934,269 1.50 2,931,269 1,006
Clearing Members 610,326 0.31 610,326 4
Directors of their Relatives 130,972 0.07 130,972 7
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,260,226 1.66 3,259,726 10,604
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,127,803 0.57 1,127,703 3,774
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,246,561 3.18 6,246,561 20
Individuals holding nominal share capital up to Rs. 1 lakh 38,435,067 19.59 38,124,792 388,531
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 3,270 0.00 3,270 6
Others 866,453 0.44 866,453 2
Sub Total 54,136,604 27.60 53,822,729 404,091
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 196,167,952 100.00 195,854,077 404,384

Company Background

Natco Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Natco Pharma Ltd
  • BSE Code : 4684.0
  • ISIN : INE987B01026

  • Incorporation Year

    1981

  • Registered Office

    Natco House
    Road No 2 Banjara Hills, Hyderabad,
    Telangana-500033

  • Telephone

    91-040-23547532

  • FAX

    91-040-23548243

  • Chairman

    V C Nannapaneni

  • Managing Director

    V C Nannapaneni

  • Company Secretary

    Venkat Ramesh

  • Auditor

    B S R & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Natco Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Natco Pharma 789.60 3,875.70 3,594.60 17.37 16.42
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77